Slide deck
BackDRT3 — A Defence System That Templates DNA on a Protein
A bacterial defence enzyme, Drt3b, builds DNA with its own amino acids standing in for a template. It makes one alternating repeat, and a second group has shown what it is for: the product builds up when a phage disables RecBCD, and the cell shuts down.
Reverse transcriptase · Central dogma · Science, 16 April 2026
A Way of Making DNA in Which the Protein Is the Blueprint
A bacterial defence enzyme builds DNA with its own amino acids standing in for a template, and makes one alternating repeat.
DRT3 — protein-templated DNA1 / 15
What happened
The Finding in Four Numbers
- 2 RTDRT3 pairs a conventional Drt3a with an unconventional Drt3b
- 2.6 Åresolution of the cryo-EM structures of the Drt3a:Drt3b:ncRNA complex
- 6:6:6stoichiometry of that complex: six copies of each component
- 20bacterial phyla across which DRT3 relatives are scattered, at least
DRT3 — protein-templated DNA2 / 15
What happened · the mechanism
A Conventional Drt3a, an Unconventional Drt3b
- Drt3a copies a short motif in the system’s own non-coding RNA to make one strand of the repeat.
- Drt3b makes the complementary strand with no nucleic acid in its active site at all. Two side chains, Glu26 and Arg253, pick each base in turn.
- The two strands anneal, and the cell ends up with a double-stranded repeat whose sequence a protein decided.
DRT3 — protein-templated DNA3 / 15
What happened · the structure
Peer-Reviewed, and Resolved by Cryo-EM
How firm What Who says so Confirmed DRT3 is a ribonucleoprotein complex of Drt3a, Drt3b and a non-coding RNA that makes alternating poly(GT/AC) double-stranded DNA; cryo-EM resolves a D3-symmetric 6:6:6 assembly at 2.6 ångström Science, peer-reviewed, read in full (PMID 41990131) Confirmed Two conserved residues in Drt3b, Glu26 and Arg253, select the incoming base; a tyrosine at the protein’s own end, Tyr650, starts the strand. Change Glu26 and the product truncates and misincorporates; change Tyr650 and defence stops Science, peer-reviewed, read in full DRT3 — protein-templated DNA4 / 15
What others add · the defence
The Defence Question, Answered in Part
- RecBCD, the host’s own exonuclease-helicase, degrades the DNA product continuously and keeps it below a toxic level.
- Gam, a phage protein, disables RecBCD. The product then builds up and the cell arrests itself, ending the infection with it.
- ST61, a gene of phage T1, is what every escape mutant in the original paper had broken.
DRT3 — protein-templated DNA5 / 15
What others add · the defence
Two Explanations Tested and Set Aside
- It does not work by exhausting the cell’s nucleotides: profiling found no depletion, infected or not.
- It is not the SOS damage response: cells that cannot mount one still defend themselves.
- What the accumulated DNA actually does — sponge, signal, scaffold or poison — is still the open question, and whether the repeat folds into left-handed Z-DNA is written down as unresolved.
DRT3 — protein-templated DNA6 / 15
The argument
Does It Touch the Central Dogma?
Position Argument A challenge, and not the first
Figiel and Nowotny, in CellTheir preview is titled for the claim that reverse transcriptases challenge the central dogma again, and calls the way the two enzymes build the double strand an unprecedented process. An expansion, not a rewriting
Yaojun TongIt would be tempting, he writes, to frame these studies as a rewriting of the central dogma, and that would be too strong: no direct flow from a protein’s sequence to a DNA sequence is demonstrated. What is shown is that proteins can decide how a DNA product is made. No dogma broken
Rafael Pinilla-Redondo (Copenhagen)“No, I would not say the central dogma has been broken,” he told an interviewer: what the study shows is a protein helping to build a short, repetitive sequence in a very specific context. The exciting part, he says, is that evolution found an unexpected way to build a DNA molecule. DRT3 — protein-templated DNA7 / 15
The argument
And What the Paper Itself Says
Position Argument A rigid, single-purpose machine
Nikolai Slavov (Northeastern)Drt3b is a highly specialised structural constraint, he wrote in a public comment: a “stuttering” machine physically keyed to produce one simple repetitive sequence, not a protein reading itself to create a complex message. The dogma was never the point
Anna MeldolesiThe central dogma is by now more a rhetorical device than a law, she argues, and the headline missed the detail that decides the question: all the enzyme does is assemble two letters and repeat them. What the paper itself establishes The product is one alternating repeat, and the authors write that the six bases nearest the end of the strand all touch amino acid side chains — which, they say, suggests Drt3b cannot easily be reprogrammed for another sequence without losing efficiency. DRT3 — protein-templated DNA8 / 15
What others add
One Enzyme Fold, a Family of Outputs
- Bacterial defence: reverse transcriptases turn up as a rapidly expanding set of clades inside bacterial immunity, sitting alongside CRISPR-associated ones in the same defence islands. CRISPR itself began as a bacterial defence system before it became a laboratory tool.
- Building a gene that is not in the genome: the DRT2 system reverse-transcribes a non-coding RNA round and round to assemble a toxic protein the chromosome does not encode. Given a rewritten template it has been made to produce a chosen double-stranded DNA in living cells.
- Other outputs again: DRT1 makes semi-random single-stranded DNA and shuts itself off in filaments; DRT9 makes long runs of a single letter; DRT10 adds repeats the way telomerase does, and the phylogeny puts telomerase in one clade with the family.
- Drt3b: it goes further than the rest of the class in one respect — the sequence is set by the protein and not by any nucleic acid. Work since suggests this is not confined to DRT3: a preprint describes a fused enzyme, DRT7, that also writes DNA on a protein template.
DRT3 — protein-templated DNA9 / 15
What others add
Not the Only One
- 1.5%of a bacterium’s genes are predicted to be anti-phage systems
- DRT10adds repeats as telomerase does, and shares a clade with it
- 20bacterial phyla hold a relative of DRT3, at least
DRT3 — protein-templated DNA10 / 15
What others add · the limits
What Has Not Been Shown
- Drt3b has not been made to produce any sequence other than its own alternating repeat. The review that states this calls it structural control of specificity without programmability.
- No application has been validated in a mammalian system or model.
- A researcher asked directly whether it could be engineered answered that we do not yet know whether it can be reprogrammed or engineered in a useful way.
- Any medical use would first have to settle how long the enzyme persists, what accumulating DNA does inside a cell, whether it sets off the innate immune system, and whether it damages the genome.
DRT3 — protein-templated DNA11 / 15
Timeline
April to June 2026
- 16 Apr 2026Science publishes Deng, Lee, Armijo, Wang and Gao on DRT3: the two reverse transcriptases, the non-coding RNA, the 2.6 ångström structures and the phage T1 trigger ST61. A news article in the same issue carries the finding to a wider readership.
- 20 May 2026Synthetic and Systems Biotechnology publishes Yaojun Tong’s commentary placing DRT3 inside a class of defence reverse transcriptases that write unconventional DNA, and warning that calling it a rewriting of the central dogma would be too strong.
- 1 Jun 2026A broadcaster’s science desk interviews Gao, Philip Kranzusch of Harvard Medical School and Rafael Pinilla-Redondo of the University of Copenhagen. Kranzusch calls the research groundbreaking; Pinilla-Redondo says the dogma has not been broken.
DRT3 — protein-templated DNA12 / 15
Timeline
July to October 2026
- 16 Jun 2026Frontiers in Microbiology publishes Sarfaraz Niazi’s review, which states the limits plainly: structural control of sequence without programmability, and no validated application in a mammalian system.
- 28 Jul 2026Cell publishes Wang and colleagues, at Columbia and the University of Tokyo: the product is held down by RecBCD, released by the phage protein Gam, and the cell then shuts itself down. A screen also finds the host factor GreA is needed.
- 2 Sep 2026Cell Host & Microbe reports that a cousin system, DRT2, has been given a rewritten RNA template and made to produce a user-defined double-stranded DNA inside living cells.
- 12 Oct 2026Nature reports DRT10, which adds DNA repeats the way telomerase does, and places telomerase in one clade with the defence reverse transcriptases — a common origin for the chemistry.
DRT3 — protein-templated DNA13 / 15
Conclusion
What to Take Away
The mechanism is settled; the meaning is not
That a protein’s own side chains can fix the sequence of a DNA strand is peer-reviewed, resolved by cryo-EM and repeated by a second laboratory. What it means for the central dogma is an argument among named scientists, with a Cell preview on one side and the commentary and the interviews on the other, and this page carries both rather than picking.
The defence answer came from elsewhere
The account of what the DNA is for — held down by RecBCD, released when a phage attacks RecBCD, and the cell then stopping itself — comes from a group at Columbia and the University of Tokyo, not from the laboratory that first described DRT3. What the DNA actually does once it accumulates is still the open part.
DRT3 — protein-templated DNA14 / 15
Conclusion
And What Would Have to Change
Early days for engineering
Drt3b still makes one repeat and nothing else, and the contrast within its own family is instructive: a cousin system whose specificity lives in an RNA template has been reprogrammed to make a chosen sequence, while this one’s specificity is built into the protein, which is exactly what makes it hard to move.
DRT3 — protein-templated DNA15 / 15